The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low tumor-infiltrating lymphocytes (TILs) to predict and refine risk in patients not achieving a pathological complete response (pCR) in HER2-positive breast cancers.
 
Naoki Hayashi
Honoraria - Chugai Pharma; Devicor Medical Products; Eisai; Genomic Health; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
 
Giampaolo Bianchini
Honoraria - Eisai; Genomic Health; Roche Pharma AG
Consulting or Advisory Role - Genomic Health
Patents, Royalties, Other Intellectual Property - Roche
 
Michiko Murai
No Relationships to Disclose
 
Koyu Suzuki
No Relationships to Disclose
 
Mieko Uno
No Relationships to Disclose
 
Shiro Uchida
No Relationships to Disclose
 
Hiroshi Yagata
No Relationships to Disclose
 
Atsushi Yoshida
Honoraria - Kyowa Hakko Kirin; Pfizer
 
Takayuki Iwamoto
No Relationships to Disclose
 
Naoki Niikura
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Kyowa Hakko Kirin; Nihon Medi-Physics; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Chugai Pharma (Inst); Nihon Medi-Physics; Sanofi
 
Seigo Nakamura
Honoraria - Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Novartis (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Hideko Yamauchi
Honoraria - Astellas Pharma; Daiichi Sankyo; Devicor Medical Products; Eisai; Falco biosystems; Genomic Health; Lilly Japan; Nihon medi-physics; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda